Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)
Egypt · Delayed Price · Currency is EGP 144.10
-11.28 (-7.26%)
At close: Sep 9, 2025
EGX:MPCI Revenue
Memphis Pharmaceuticals & Chemical Industries had revenue of 309.36M EGP in the quarter ending March 31, 2025, with 31.76% growth. This brings the company's revenue in the last twelve months to 1.30B, up 46.92% year-over-year. In the fiscal year ending June 30, 2024, Memphis Pharmaceuticals & Chemical Industries had annual revenue of 871.91M with 31.34% growth.
Revenue (ttm)
1.30B
Revenue Growth
+46.92%
P/S Ratio
2.13
Revenue / Employee
10.47M
Employees
144
Market Cap
3.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 871.91M | 208.07M | 31.34% |
| Jun 30, 2023 | 663.83M | 112.57M | 20.42% |
| Jun 30, 2022 | 551.26M | 33.15M | 6.40% |
| Jun 30, 2021 | 518.11M | 29.70M | 6.08% |
| Jun 30, 2020 | 488.41M | 125.34M | 34.52% |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition